VTVT
vTv TherapeuticsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
VTVT vs peer average
92/100
VTVT vs. peer average (A vs. D)
Grade spread
B 1 · C 6 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
MXCT is the first available peer comparator.
Adjacency comp by size more than program similarity; useful as a reminder that sub-$200 million life-science companies can trade heavily on partnership, funding, and execution milestones.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
VTVT
vTv Therapeutics
MXCT
MaxCyte
Grade
A
F
Momentum
26
19
Value
41
41
Sentiment
90
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs MXCT
VTVT / MXCT
Grade Position
Above peers
VTVT vs. peer average (A vs. D)
92/100
Momentum
26
VTVTValue
41
VTVTSentiment
90
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs VTVT
MXCT is the first peer returned for this comparison set.